 |
|
|
| |
Sofosbuvir/Velpatasvir for Patients With Chronic Genotype 3 HCV Infection With Compensated Cirrhosis: an Integrated Analysis of Phase 2 and Phase 3 Clinical Trials
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-12 Boston
Stuart K. Roberts,1 Maria Buti,2 Graham R. Foster,3 Jose Luis Calleja,4 Ajit Sood,5 Vasily A. Isakov,6 Ola Weiland,7 Luisa M. Stamm,8 Liyun Ni,8 Evguenia Svarovskaia,8 Diana M. Brainard,8 David L. Wyles,9 Juan A. Pineda,10 Alexander Thompson,11 Rafael Esteban,2 Alessandra Mangia12
1The Alfred, Melbourne, Victoria, Australia; 2Vall d'Hebron Barcelona Campus Hospitalari, Barcelona, Spain; 3Queen Mary University of London, UK; 4Hospital Universitario Puerta de Hierro, CIBERehd, Madrid, Spain; 5Dayanand Medical College & Hospital, Ludhiana, India; 6Dept of Gastroenterology & Hepatology, Federal Research Center of Nutrition and Biotechnology, Moscow, Russia; 7Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden; 8Gilead Sciences, Inc., Foster City, CA; 9Denver Health, Denver, CO; 10Hospital Universitario Virgen de Valme, Sevilla, Spain; 11St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia; 12Liver Unit, Istituto di Ricovero e Cura a Carattere Scientifico-Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy
References: 1. Tapper EB, Afdhal NH. J Viral Hepatol 2013;20:669-77; 2. Jacobson IM, et al. N Engl J Med 2013;368:1867-77; 3. Lawitz E, et al. N Engl J Med 2013;368:1878-87; 4. Cheng G, et al. EASL 2013, poster 1191; 5. German P, et al. EASL 2013, poster 1195; 6. Lawitz E, et al. J Vir Hep 2015;22:1011-9; 7. Buggisch P, et al. EASL 2017, poster SAT-254; 8. Curry MP, et al. N Engl J Med 2015;373:2618-28; 9. Curry MP, et al. EASL 2017, PS-102; 10. Feld J, et al. N Engl J Med 2015;373:2599-607; 11. Foster G, et al. N Engl J Med 2015;373:2608-17; 12. Landis C, et al. AASLD 2017, abstr 1096; 13. Esteban R, et al. Gastroenterology 2018;155:1120-7; 14. Jacobson IM, et al. Gastroenterology 2017;153:113-22; 15. Sood A, et al. Hepatol Int 2018;12(Suppl 2):S240 [abstr O-HCV-12]; 16. Weiland O, et al. Hepatology 2017;66(Suppl 1):639A [abstr 1186]; 17. Wyles D, et al. Clin Infect Dis 2017;65:6-12.
|
| |
|
|
|
|
|
